Humoral Response to mRNA-1273 SARS-CoV-2 Vaccine in Peritoneal Dialysis Patients: Is Boostering After Six Months Adequate?

Humoral Response to mRNA-1273 SARS-CoV-2 Vaccine in Peritoneal Dialysis Patients: Is Boostering After Six Months Adequate?

In dialysis patients the humoral response to anti-SARS-CoV-2 vaccines is attenuated and rapidly declines over time. However, data on the persistence of the immune response in peritoneal dialysis (PD) patients are scarce, particularly after a third (booster) dose with mRNA-1273 vaccine. In this prosp...

Full description

Bibliographic Details
Main Authors: Georg Beilhack, Rossella Monteforte, Florian Frommlet, Roman Reindl-Schwaighofer, Robert Strassl, Andreas Vychytil
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Medicine
Subjects:
COVID-19
peritoneal dialysis
anti-SARS-CoV-2 antibodies
booster
mRNA-1273 vaccine
spikevax
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.905798/full

Similar Items

Similar Items